Literature DB >> 15006430

Effects of recurrent major depressive disorder on behavior and cognitive function in female depressed patients.

Indrag K Lampe1, Margriet M Sitskoorn, Thea J Heeren.   

Abstract

Little is known about the effects of recurring depressive episodes on cognition and behavior. The objective of the study was to compare cognitive function and depression-related behavior between healthy female subjects and female outpatients with early-onset DSM-IV recurrent major depressive disorder and to investigate the effect of cumulative depressive duration. Neuropsychological tests and scales for apathy, anhedonia and psychomotor retardation were assessed in 23 female patients and 60 healthy age-matched female controls. Significantly higher levels of apathy, anhedonia and psychomotor retardation, and worse performance on tests of executive function were found in the patient group compared with the healthy controls. In the patient group, cumulative depression duration was not significantly correlated with cognitive function, apathy, anhedonia or psychomotor retardation. The deficits in executive function were not related to the actual level of depression. Mild executive dysfunction may be the effect of the illness process underlying recurrent depressive disorder. Repeated or extensive depressive episodes do not seem to additionally affect cognitive deficits or behavior in depressed patients.

Entities:  

Mesh:

Year:  2004        PMID: 15006430     DOI: 10.1016/j.psychres.2003.12.004

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  11 in total

Review 1.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

2.  Domain-specific impairment in cognitive control among remitted youth with a history of major depression.

Authors:  Amy T Peters; Rachel H Jacobs; Natania A Crane; Kelly A Ryan; Sara L Weisenbach; Olusola Ajilore; Melissa Lamar; Michelle T Kassel; Laura B Gabriel; Amy E West; Jon-Kar Zubieta; Scott A Langenecker
Journal:  Early Interv Psychiatry       Date:  2015-07-14       Impact factor: 2.732

3.  Neuropsychological and hypothalamic-pituitary-axis function in female patients with melancholic and non-melancholic depression.

Authors:  Ioannis Michopoulos; Iannis M Zervas; Chris Pantelis; Eleftheria Tsaltas; Vassiliki-Maria Papakosta; Fotini Boufidou; Chrissoula Nikolaou; Charalambos Papageorgiou; Costas R Soldatos; Lefteris Lykouras
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

4.  Neuropsychological deficits in major depression reflect genetic/familial risk more than clinical history: a monozygotic discordant twin-pair study.

Authors:  Kean J Hsu; Kelly C Young-Wolff; Kenneth S Kendler; Lisa J Halberstadt; Carol A Prescott
Journal:  Psychiatry Res       Date:  2013-11-05       Impact factor: 3.222

Review 5.  A Systematic Review and Meta-Analysis of Cognitive Training in Adults with Major Depressive Disorder.

Authors:  C Woolf; A Lampit; Z Shahnawaz; J Sabates; L M Norrie; D Burke; S L Naismith; L Mowszowski
Journal:  Neuropsychol Rev       Date:  2021-04-28       Impact factor: 7.444

6.  Association Between Elevated Depressive Symptoms and Cognitive Function Moderated by APOE4 Status: Framingham Offspring Study.

Authors:  Ryan J Piers; Yulin Liu; Ting F A Ang; Qiushan Tao; Rhoda Au; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 7.  Cognitive Dysfunction in Major Depressive Disorder. A Translational Review in Animal Models of the Disease.

Authors:  Flavie Darcet; Alain M Gardier; Raphael Gaillard; Denis J David; Jean-Philippe Guilloux
Journal:  Pharmaceuticals (Basel)       Date:  2016-02-17

8.  Cognitive functioning in major depression--a summary.

Authors:  Asa Hammar; Guro Ardal
Journal:  Front Hum Neurosci       Date:  2009-09-25       Impact factor: 3.169

9.  Learning and memory impairments in a neuroendocrine mouse model of anxiety/depression.

Authors:  Flavie Darcet; Indira Mendez-David; Laurent Tritschler; Alain M Gardier; Jean-Philippe Guilloux; Denis J David
Journal:  Front Behav Neurosci       Date:  2014-05-01       Impact factor: 3.558

Review 10.  Cognitive remission: a novel objective for the treatment of major depression?

Authors:  Beatrice Bortolato; Kamilla W Miskowiak; Cristiano A Köhler; Michael Maes; Brisa S Fernandes; Michael Berk; André F Carvalho
Journal:  BMC Med       Date:  2016-01-22       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.